During a Case-Based Roundtable® event, Natalie Galanina, MD, discussed data from the ZUMA-7 and TRANSFORM trials in the first ...

From crippling fatigue to brain fog, CML treatment can affect your body in ways that go beyond the usual side effects.

Northeast Ohio cancer survivor Samantha Skowron feels immense gratitude towards St Jude Children's Research Hospital for many reasons. Diagnosed with Hodgkin's Lymphoma at the age of 14, Samantha is ...

SELLAS Life Sciences Group (NASDAQ:SLS) announced on Thursday promising mid-stage trial results for SLS009, a highly ...

- Combination Achieved a 67% of Overall Response Rate, More than Double that of Zanubrutinib Alone; 83% Disease Control Rate in Difficult-to-Treat Non-GCB DLBCL (ABC DLBCL) Patients - ...

A new treatment, lisocabtagene maraleucel, has been approved for NHS use, benefiting hundreds of blood cancer patients in ...

Hundreds of people with aggressive blood cancer will be offered a groundbreaking one-off personalised therapy that ...

A Horsham man counts himself as ‘the luckiest man alive’ after receiving life-changing treatment for blood cancer.

Final NICE guidance recommends lisocabtagene maraleucel (also called liso-cel or Breyanzi and made by Bristol Myers Squibb) as an option for treating people with large B-cell lymphoma ...